IQI
ASMB icon

Integrated Quantitative Investments’s Assembly Biosciences ASMB Stock Holding History

Integrated Quantitative Investments’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$277K Buy
+10,078
New +$274K 0.05% 336

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Integrated Quantitative Investments's ASMB Position: Q2 2026 in Review

Integrated Quantitative Investments opened a new position in Assembly Biosciences (ASMB) in Q2 2026: 10,078 shares worth $277K. The stake represents 0.05% of the portfolio and ranks #336 among its holdings.

93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • Integrated Quantitative Investments held 10,078 shares of Assembly Biosciences worth $277K as of Q2 2026.
  • Assembly Biosciences was a new Integrated Quantitative Investments position in Q2 2026.
  • Assembly Biosciences made up 0.05% of Integrated Quantitative Investments's portfolio in Q2 2026, its #336 holding.
  • 93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Integrated Quantitative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.